MAIA Biotechnology Inc. Company Profile
NYSE: MAIAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 9:49 AM ET
MAIA Biotechnology at a glance
MAIA Biotechnology Inc. (NYSE: MAIA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Chicago, IL. MAIA Biotechnology is led by Dr. Vlad Vitoc M.B.A., M.D. and employs about 13 people. The company's shares have traded publicly since 2022.
At a market capitalization of $71.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001878313, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does MAIA Biotechnology do?
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Business description based on the company's public filings.
Company information
- Legal name
- MAIA Biotechnology Inc.
- Ticker
- NYSE: MAIA
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Vlad Vitoc M.B.A., M.D.
- Employees
- 13
- Headquarters
- 444 West Lake Street, Chicago, IL, United States
- Phone
- 312 416 8592
- Website
- maiabiotech.com
- IPO year
- 2022
- Market cap
- $71.00M
- SEC CIK
- 0001878313
- Latest annual report
- 10-K · Mar 23, 2026
Companies similar to MAIA Biotechnology
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FBIOFortress Biotech Inc. | 2.13 | +1.91% | $71.04M | vs MAIA |
| HYFTMindWalk Holdings Corp. | 1.50 | +5.22% | $70.88M | vs MAIA |
| GANXGain Therapeutics Inc. | 1.63 | +0.93% | $71.14M | vs MAIA |
| CINGCingulate Inc. | 4.90 | +0.41% | $71.25M | vs MAIA |
| TENXTenax Therapeutics Inc. | 1.88 | +0.81% | $70.17M | vs MAIA |
| NTHINeOnc Technologies Holdings Inc. | 2.50 | -1.15% | $72.04M | vs MAIA |
| NMADNomad Power Solutions Inc. | 4.32 | +1.17% | $69.56M | vs MAIA |
| ONCYOncolytics Biotech Inc. | 0.527 | -3.20% | $69.10M | vs MAIA |